OpGen, Inc. Made Headway

Tue, Mar 26, 2024 at 07:19 PM

OpGen, Inc. (OPGN:NASDAQ) jumped higher at $0.75, representing a gain of 57.9%. On Tue, Mar 26, 2024, OPGN:NASDAQ touched a New 2-Week High of $0.75. The stock got featured on our News Catalysts scanner on Mon, Mar 25, 2024 at 06:32 PM in the 'ACQUISITION' category. From Tue, Mar 12, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Tue, Mar 26, 2024 at $0.99 with a volume of 76M+.

About OpGen, Inc. (OPGN:NASDAQ)

OpGen Inc is an precision medicine company using molecular diagnostics and bioinformatics to help combat infectious disease.

Top 10 Gainers:

SRAX, Inc. (SRAX:NASDAQ), 111.11%
Mesoblast Limited (MESO:NASDAQ), 78.64%
Cazoo Group Ltd Class A (CZOO:NYSE), 61.08%
Stoke Therapeutics, Inc. (STOK:NASDAQ), 58.31%
OpGen, Inc. (OPGN:NASDAQ), 57.86%
Concord Medical Services Holdings Limited (CCM:NYSE), 47.66%
Krispy Kreme Inc. (DNUT:NASDAQ), 39.36%
C3is Inc. (CISS:NASDAQ), 36.65%
AirNet Technology Inc. (ANTE:NASDAQ), 34.15%
Puyi Inc. (PUYI:NASDAQ), 33.93%